| TRADING CENTER |
| Cytori Completes Enrollment in International Breast Cancer Reconstruction Study; Inte... - Business Wire | |
| 5-Star Stocks on the Upswing - MotleyFool.com | |
| Cytori Reports 3rd Quarter 2009 Financial Results - Business Wire | |
| Cytori Therapeutics to Webcast Third Quarter Financial Results on November 9, 2009 - Business Wire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 55.91 | 0.53 / 0.96% | 10.69 |
| GILD | Gilead Sciences Inc | 46.59 | 0.20 / 0.43% | 17.99 |
| CELG | Celgene Corporation | 55.01 | 0.10 / 0.17% | 66.27 |
| 2008 Revenue: | $4.5 M | Headquarters: San Diego, CA |
| Employees: | 126 | CEO: Christopher J. Calhoun |
| Net Income: | $-30,036,000.0 | Industry: Biotechnology |
| Market Cap: | $167.0 M | Website: www.cytoritx.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| CYTX | 4.40 | +0.09 / +2.09% | 4.31 | 4.53 | 4.32 | Profile Chart News |